Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 367.07 billion as of February 21, 2025. Its market cap has increased by 48.29% in one year.

Market Cap

367.07B

Enterprise Value

366.67B

Revenue

139.61B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,349.00

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 367.07B, an increase of 31,838.51%. That is a compound annual growth rate of 27.51%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	367.07B	-19.16%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	15.61T
Tata Consultancy Services	13.70T
HDFC Bank	12.95T
Bharti Airtel	9,798.65B
ICICI Bank	8,708.47B
Infosys	7,518.72B
State Bank of India	6,443.58B
Hindustan Unilever	5,266.96B

Market Cap Rankings